Clinical Trial Update: Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)

View source ↗

Summary

ClinicalTrials.gov entry TALENP003 describes a trial of triple therapy sequential radiotherapy for unresectable hepatocellular carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fujian Provincial Hospital | Conditions: Hepatocellular Carcinoma Non-resectable | Status: RECRUITING